• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从大鼠肾脏和尿液中分离草酸钙晶体生长抑制剂。

Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine.

作者信息

Nakagawa Y, Abram V, Coe F L

出版信息

Am J Physiol. 1984 Nov;247(5 Pt 2):F765-72. doi: 10.1152/ajprenal.1984.247.5.F765.

DOI:10.1152/ajprenal.1984.247.5.F765
PMID:6496744
Abstract

Glycoproteins that slow the growth rate of calcium oxalate monohydrate crystals were purified from rat kidney homogenate and urine by selective heat denaturation (for rat kidney homogenate), DEAE-cellulose column chromatography, and gel permeation column chromatography. Both kidney and urine inhibitors were glycoproteins with an apparent mol wt of 1.4 X 10(4), as determined by high-performance liquid chromatography. They contained gamma-carboxyglutamic acid and a high percentage of aspartic acid and glutamic acid but had few aromatic amino acid residues. Both inhibitors contained fucose, mannose, glucose, galactose, glucosamine, galactosamine, and N-acetylneuraminic acid but no glucuronic acid. Kinetic studies suggest that purified inhibitors bind to calcium oxalate monohydrate seed crystals according to a Langmuir adsorption isotherm with similar dissociation constants of 14 X 10(-8)M for rat urine inhibitor and 8.7 X 10(-8) M for rat kidney inhibitor. The isolation of similar glycoproteins from kidney and urine suggests that urinary crystal growth inhibitor may be produced in the kidneys.

摘要

通过选择性热变性(用于大鼠肾脏匀浆)、DEAE - 纤维素柱色谱和凝胶渗透柱色谱,从大鼠肾脏匀浆和尿液中纯化出了减缓一水合草酸钙晶体生长速率的糖蛋白。通过高效液相色谱测定,肾脏和尿液中的抑制剂均为糖蛋白,表观分子量为1.4×10⁴。它们含有γ - 羧基谷氨酸以及高比例的天冬氨酸和谷氨酸,但芳香族氨基酸残基较少。两种抑制剂都含有岩藻糖、甘露糖、葡萄糖、半乳糖、氨基葡萄糖、半乳糖胺和N - 乙酰神经氨酸,但不含葡萄糖醛酸。动力学研究表明,纯化后的抑制剂根据朗缪尔吸附等温线与一水合草酸钙籽晶结合,大鼠尿液抑制剂的解离常数类似,为14×10⁻⁸M,大鼠肾脏抑制剂的解离常数为8.7×10⁻⁸M。从肾脏和尿液中分离出相似的糖蛋白表明,尿液晶体生长抑制剂可能在肾脏中产生。

相似文献

1
Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine.从大鼠肾脏和尿液中分离草酸钙晶体生长抑制剂。
Am J Physiol. 1984 Nov;247(5 Pt 2):F765-72. doi: 10.1152/ajprenal.1984.247.5.F765.
2
Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.人尿中一水草酸钙晶体生长主要抑制剂的纯化与特性研究
J Biol Chem. 1983 Oct 25;258(20):12594-600.
3
Isolation of nephrocalcin from kidney tissue of nine vertebrate species.从九种脊椎动物的肾脏组织中分离出肾钙蛋白。
Am J Physiol. 1991 Feb;260(2 Pt 2):F243-8. doi: 10.1152/ajprenal.1991.260.2.F243.
4
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.从人草酸钙肾结石中分离出肾钙蛋白,一种草酸钙晶体生长的糖蛋白抑制剂。草酸钙肾结石患者的肾钙蛋白缺乏γ-羧基谷氨酸的证据。
J Clin Invest. 1987 Jun;79(6):1782-7. doi: 10.1172/JCI113019.
5
Glycoprotein calcium oxalate crystal growth inhibitor in urine.尿液中的糖蛋白草酸钙晶体生长抑制剂。
Miner Electrolyte Metab. 1987;13(4):267-72.
6
Growth inhibitor of calcium oxalate monohydrate crystal in vitamin B6-deficient rat urine and kidney.
J Nutr Sci Vitaminol (Tokyo). 1988 Feb;34(1):79-84. doi: 10.3177/jnsv.34.79.
7
A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
BJU Int. 2000 Jul;86(1):7-13. doi: 10.1046/j.1464-410x.2000.00725.x.
8
Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.用31P核磁共振波谱仪阐明肾钙素的多种形式。
FEBS Lett. 1989 Jul 3;250(2):187-90. doi: 10.1016/0014-5793(89)80717-3.
9
Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.钙性肾结石中尿糖蛋白晶体生长抑制剂的分子异常
Trans Assoc Am Physicians. 1985;98:281-9.
10
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.尿糖蛋白晶体生长抑制剂。草酸钙肾结石分子异常的证据。
J Clin Invest. 1985 Oct;76(4):1455-62. doi: 10.1172/JCI112124.

引用本文的文献

1
Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.磷酸二钙二水合物与羟基磷灰石尿结晶抑制剂之间的协同作用。
Int Urol Nephrol. 2002;34(4):447-51. doi: 10.1023/a:1025671019653.
2
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
3
Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.糖胺聚糖、蛋白质与结石形成:成人话题与儿童游戏
Pediatr Nephrol. 1996 Oct;10(5):656-66. doi: 10.1007/s004670050185.
4
Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.从人尿中分离纯化一种抑制草酸钙结晶的新型糖蛋白。
Urol Res. 1993 Jan;21(1):61-6. doi: 10.1007/BF00295195.
5
The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.华法林对草酸钙尿结晶生长抑制及钙和肾钙素尿排泄的影响。
Calcif Tissue Int. 1993 Oct;53(4):242-8. doi: 10.1007/BF01320909.
6
Characterization of calcium-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin with vanadyl ions: electron paramagnetic resonance and electron nuclear double resonance spectroscopy.用钒离子对肾结石抑制剂糖蛋白肾钙蛋白中钙结合位点的表征:电子顺磁共振和电子核双共振光谱法
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11323-7. doi: 10.1073/pnas.91.24.11323.
7
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.尿糖蛋白晶体生长抑制剂。草酸钙肾结石分子异常的证据。
J Clin Invest. 1985 Oct;76(4):1455-62. doi: 10.1172/JCI112124.
8
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.从人草酸钙肾结石中分离出肾钙蛋白,一种草酸钙晶体生长的糖蛋白抑制剂。草酸钙肾结石患者的肾钙蛋白缺乏γ-羧基谷氨酸的证据。
J Clin Invest. 1987 Jun;79(6):1782-7. doi: 10.1172/JCI113019.